Skip to main content
Back to News
Boston-based Neurable secured $35M in Series A funding led by Spectrum Moonshot Fund, totaling $65M.
Funding
1 min read
US

Boston-based Neurable secured $35M in Series A funding led by Spectrum Moonshot Fund, totaling $65M.

The AMW Read

The article updates the player map for the neurotechnology/health-tech vertical with a $35M Series A, but does not meet the $500M threshold for cross.§D.
NoveltySignificance
Healthcare & Bio · Player Map

Boston-based Neurable secured $35M in Series A funding led by Spectrum Moonshot Fund, totaling $65M. This investment signals the transition of brain-computer interfaces from surgical implants to mass-market wearables using an AI-first licensing model. By localizing EEG processing to track cognitive fatigue, Neurable is building a standard operating system for neural data. Brain-activity metrics are now set to become a universal biometric for workplace safety and consumer electronics by 2026. 🧠💻

#NeuroTech #BCI #AI #HealthTech #Funding

How This Connects

Based on Healthcare & Bio · Player Map

  1. 1w agoAdaptyv raises €34.35M Series A for automated protein-design labAdaptyv
  2. 2w agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  3. 2w agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  4. 8mo agoBoston-based Neurable secured $35M in Series A funding led by Spectrum Moonshot Fund, totaling $65M. · THIS ARTICLE

More news from Neurable

Stay updated with the latest news and announcements from Neurable.

View all Neurable news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard